ArticleLeukemia2021

Characterization of p190-Bcr-Abl chronic myeloid leukemia reveals specific signaling pathways and therapeutic targets.

Shady Adnan-Awad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.